Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne H Cross

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Ebiomedicine|June 24, 2023
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trialsAmit Bar-Or, Gian-Andrea Thanei, Christopher Harp, et al.
Contemporary Clinical Trials|May 31, 2024
Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restrictionKat Martin, Stacey S Cofield, Anne H Cross, et al.
Ebiomedicine|August 29, 2021
Alterations of the gut mycobiome in patients with MSSaumya Shah, Alberto Locca, Yair Dorsett, et al.
Human Genetics|January 30, 2010
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibilityRebecca L Zuvich, Jacob L McCauley, Jorge R Oksenberg, et al.
Multiple Sclerosis and Related Disorders|June 25, 2023
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trialMitzi J Williams, Annette F Okai, Anne H Cross, et al.
Neurology|June 18, 2013
Genetic risk variants in African Americans with multiple sclerosisNoriko Isobe, Pierre-Antoine Gourraud, Hanne F Harbo, et al.
Neurology|November 3, 2017
High risk of postpartum relapses in neuromyelitis optica spectrum disorderEric C Klawiter, Riley Bove, Liene Elsone, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 7, 2017
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter studyRiley Bove, Liene Elsone, Enrique Alvarez, et al.
Nature Immunology|April 19, 2017
Speaking out about gender imbalance in invited speakers improves diversityRobyn S Klein, Rhonda Voskuhl, Benjamin M Segal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 yearsStephen L Hauser, Anne H Cross, Kevin Winthrop, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Ebiomedicine|June 24, 2023
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trialsAmit Bar-Or, Gian-Andrea Thanei, Christopher Harp, et al.
Contemporary Clinical Trials|May 31, 2024
Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restrictionKat Martin, Stacey S Cofield, Anne H Cross, et al.
Ebiomedicine|August 29, 2021
Alterations of the gut mycobiome in patients with MSSaumya Shah, Alberto Locca, Yair Dorsett, et al.
Human Genetics|January 30, 2010
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibilityRebecca L Zuvich, Jacob L McCauley, Jorge R Oksenberg, et al.
Multiple Sclerosis and Related Disorders|June 25, 2023
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trialMitzi J Williams, Annette F Okai, Anne H Cross, et al.
Neurology|June 18, 2013
Genetic risk variants in African Americans with multiple sclerosisNoriko Isobe, Pierre-Antoine Gourraud, Hanne F Harbo, et al.
Neurology|November 3, 2017
High risk of postpartum relapses in neuromyelitis optica spectrum disorderEric C Klawiter, Riley Bove, Liene Elsone, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 7, 2017
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter studyRiley Bove, Liene Elsone, Enrique Alvarez, et al.
Nature Immunology|April 19, 2017
Speaking out about gender imbalance in invited speakers improves diversityRobyn S Klein, Rhonda Voskuhl, Benjamin M Segal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 yearsStephen L Hauser, Anne H Cross, Kevin Winthrop, et al.
Pageof 20